Asparaginyl endopeptidase improves the resistance of microtubule-targeting drugs in gastric cancer through IQGAP1 modulating the EGFR/JNK/ERK signaling pathway
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.